A recent report indicates the nuclear medicine market is expected to experience significant growth. The market is projected to reach $21.01 billion by 2030.

This growth is driven by advancements in certain areas of nuclear medicine. Molecular imaging and theranostics are key factors contributing to the market's expansion.

Further details about the report can be found in the Denton Record-Chronicle, which provides more information on the nuclear medicine market and its projected growth.